← Back to Search

WBI with SIB for Breast Cancer

N/A
Recruiting
Led By Jessica Schuster, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years post-treatment (treatment ends up to 5 weeks on study)
Awards & highlights

Study Summary

This trial is looking at how well a new type of radiation therapy works for women with breast cancer. They will assess how the treatment affects the appearance, patient-reported outcomes, and side effects. Fifty women

Who is the study for?
This trial is for women with breast cancer who are eligible for radiation therapy. Specific eligibility details aren't provided, but typically participants must be in good health aside from their cancer and meet certain medical criteria.Check my eligibility
What is being tested?
The study tests a new approach to radiation therapy called ultra-short whole breast irradiation (WBI) with simultaneous integrated boost (SIB). It aims to evaluate the cosmetic outcomes, patient satisfaction, and any side effects over a period of up to 5 years.See study design
What are the potential side effects?
While specific side effects are not listed, common ones from radiation therapy include skin irritation at the treatment site, fatigue, breast pain or swelling, and changes in skin texture.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years post-treatment (treatment ends up to 5 weeks on study)
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years post-treatment (treatment ends up to 5 weeks on study) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Harvard Breast Cosmesis Scale Score
Secondary outcome measures
Change in BREAST-Q Score
Incidence of Acute Toxicities
Incidence of Late Toxicities
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: WBI with SIBExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Radiation Therapy
2017
Completed Phase 3
~7250

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,189 Previous Clinical Trials
3,169,541 Total Patients Enrolled
36 Trials studying Breast Cancer
38,519 Patients Enrolled for Breast Cancer
Jessica Schuster, MDPrincipal InvestigatorUW Carbone Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the process of enrolling participants still ongoing for this medical study?

"Information available on clinicaltrials.gov states that this particular study is not presently seeking participants. Originally posted on March 1, 2024, with the most recent update made on February 28, 2024. It's worth noting that despite this trial being inactive in recruitment status currently, there are 32 other ongoing trials actively enrolling participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Outcomes and Cosmesis With Whole Breast Irradiation and Boost
2024. "Outcomes and Cosmesis With Whole Breast Irradiation and Boost". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06295744.
All > Milwaukee
~33 spots leftby Feb 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top